Purification of a novel DBI processing product, DBI39-75, and characterization of its binding site in rat brain

16Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This report describes the purification and characterization from rat brain of DBI39-75, a novel, biologically active processing product of diazepam binding inhibitor (DBI). We have shown that DBI39-75in nM concentrations stimulates pregnenolone synthesis in mitochondria of rat brain. Using cross-linking of125I-DBI39-75in steroidogenically active concentrations we have demonstrated for the first time that the DBI fragment has a specific high affinity binding site in rat brain. Displacement of [3H]PK 11195 and [3H]Ro5-4864 by DBI39-75indicates more complex interaction than the competitive inhibition. Collectively, the data suggest that the function of DBI39-75is mediated through a mitochondrial receptor complex which includes binding sites for PK 11195 and Ro5-4864. © 1994.

Cite

CITATION STYLE

APA

Slobodyansky, E., Antkiewicz-Michaluk, L., & Martin, B. (1994). Purification of a novel DBI processing product, DBI39-75, and characterization of its binding site in rat brain. Regulatory Peptides, 50(1), 29–35. https://doi.org/10.1016/0167-0115(94)90188-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free